In the heat of the CDK4/6 market showdown, Eli Lilly has notched an overall survival win to back Verzenio’s case against ...

Amid uncertainty over how the Trump administration would approach mRNA COVID-19 vaccines for the upcoming respiratory virus ...

For the first time, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody has shown that it can extend ...

To check the pulse on the U.S. biopharma industry, few states are better situated than the life sciences hotspot that is ...

China biotech RemeGen and its new U.S. partner Vor Bio are on a roll with their first-in-class autoimmune treatment ...

Indivior’s restructuring plan is taking shape with initial headcount reductions to help move toward a more simplified ...

A newly published report developed by a group of partners, including Sanofi, shines a light on the far-reaching impacts of ...

The advancement of Pfizer’s antibody-drug conjugate portfolio has not spared the former Seagen site—and those who helped ...

Weeks after telegraphing a series of upgrades to its Mexico operations over the next five years, Bayer is rolling up its ...

Phreesia is bringing Sesame Street to the doctor’s office. The patient activation company has partnered with the nonprofit ...

With the nod, Zemcelpro offers a first-of-its-kind option to many of the thousands of patients who are diagnosed each year in ...

In May, radiopharmaceutical drug developer Ratio Therapeutics unveiled plans to build a new research and manufacturing plant ...